Inclusion Criteria:
1. Female, aged 30-60 years;
2. Fine lines on both sides of the forehead meet Grade 1-5 according to the Skin Aging Atlas;
3. Crow's feet on both sides meet Grade 2-5 according to the Skin Aging Atlas;
4. Perioral wrinkles on both sides meet Grade 1-7 or nasolabial folds on both sides meet Grade 1-6 according to the Skin Aging Atlas;
5. Lower facial laxity and sagging meet Grade 1-5 according to the Skin Aging Atlas;
6. Subjects with consistent skin condition on both sides of the face who are scheduled to receive unipolar radiofrequency treatment;
7. Able to comply well with the study requirements and maintain a regular lifestyle throughout the study period;
8. Able to read and understand all contents of the informed consent form and voluntarily sign the ICF;
9. Agree not to use any cosmetics, medications, or health supplements that may affect the study results during the trial period.
Exclusion Criteria:
1. Allergic constitution or history of severe allergies (e.g., immediate hypersensitivity symptoms, allergic dermatitis);
2. Presence of facial skin diseases (including severe freckles, atopic dermatitis, psoriasis, acute eczema, severe acne, etc.), skin infections (including viral, bacterial, fungal), or skin masses of unknown nature;
3. Presence of large areas of birthmarks, scratch marks, vitiligo, pigmented nevi, keloids, or other skin manifestations on the face that may affect the evaluation;
4. Presence of implantable electronic devices in the body (e.g., pacemaker, implantable cardioverter-defibrillator);
5. Diagnosed with serious clinical conditions such as endocrine diseases, immune system diseases, severe organ failure, or malignant tumors;
6. Diagnosed with severe mental illness or cognitive dysfunction, deemed by the investigator as unable to complete the evaluation or questionnaires involved in the study;
7. Received or planned to receive facial radiofrequency or botulinum toxin treatment within 6 months prior to enrollment or during the study;
8. Received chemotherapy or systemic corticosteroids within 3 months prior to enrollment;
9. Received or planned to receive facial photoelectric treatments (e.g., laser, intense pulsed light), fillers (e.g., sodium hyaluronate, collagen), thread lifts, or other aesthetic procedures within 3 months prior to enrollment or during the study;
10. Received or planned to receive facial mesotherapy or chemical peeling within 1 month prior to enrollment or during the study;
11. Used cosmetics, skincare products, or topical medications with firming or anti-wrinkle claims (e.g., glycolic acid, salicylic acid, mandelic acid, tretinoin, hydroquinone, azelaic acid, adapalene, etc.) on the face within 14 days prior to enrollment;
12. Other conditions that, in the investigator's judgment, render the subject unsuitable for unipolar radiofrequency treatment;
13. Pregnant or breastfeeding women;
14. Participated in other interventional clinical trials within 1 month prior to enrollment;
15. Other circumstances under which the investigator considers the subject should not participate in this clinical trial.
